Format

Send to

Choose Destination
See comment in PubMed Commons below
Clin Cancer Res. 2010 Jun 15;16(12):3270-8. doi: 10.1158/1078-0432.CCR-10-0278. Epub 2010 Jun 8.

Biobehavioral, immune, and health benefits following recurrence for psychological intervention participants.

Author information

1
Department of Psychology, The Ohio State University, Columbus, OH 43210, USA. andersen.1@osu.edu

Erratum in

  • Clin Cancer Res. 2010 Sep 1;16(17):4490.

Abstract

PURPOSE:

A clinical trial was designed to test the hypothesis that a psychological intervention could reduce the risk of cancer recurrence. Newly diagnosed regional breast cancer patients (n = 227) were randomized to the intervention-with-assessment or the assessment-only arm. The intervention had positive psychological, social, immune, and health benefits, and after a median of 11 years the intervention arm was found to have reduced the risk of recurrence (hazard ratio, 0.55; P = 0.034). In follow-up, we hypothesized that the intervention arm might also show longer survival after recurrence. If observed, we then would examine potential biobehavioral mechanisms.

EXPERIMENTAL DESIGN:

All patients were followed; 62 recurred. Survival analyses included all 62. Upon recurrence diagnosis, those available for further biobehavioral study were accrued (n = 41, 23 intervention and 18 assessment). For those 41, psychological, social, adherence, health, and immune (natural killer cell cytotoxicity, T-cell proliferation) data were collected at recurrence diagnosis and 4, 8, and 12 months later.

RESULTS:

Intent-to-treat analysis revealed reduced risk of death following recurrence for the intervention arm (hazard ratio, 0.41; P = 0.014). Mixed-effects follow-up analyses with biobehavioral data showed that all patients responded with significant psychological distress at recurrence diagnosis, but thereafter only the intervention arm improved (P values < 0.023). Immune indices were significantly higher for the intervention arm at 12 months (P values < 0.017).

CONCLUSIONS:

Hazards analyses augment previous findings in showing improved survival for the intervention arm after recurrence. Follow-up analyses showing biobehavioral advantages for the intervention arm contribute to our understanding of how improved survival was achieved.

PMID:
20530702
PMCID:
PMC2910547
DOI:
10.1158/1078-0432.CCR-10-0278
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire Icon for PubMed Central
    Loading ...
    Support Center